does cigna cover glp 1 meds will stop covering GLP-1 weight-loss drugs including Wegovy and Zepbound in its ​employee health plan effective July 1, according to Reuters Cigna is ending employee coverage

It sits in the same category as many other research-use peptides and is sold for research reference, not human use

Regular check-ins with your prescriber allow for dose adjustments, symptom management, and early identification of any concerning patterns

Economic Impact of Patent Expiry In the GLP-1 segment, the shift from branded therapies to biosimilars and generics will: Reduce drug prices significantly over time Increase patient access, especially in price-sensitive markets Expand total treatment volumes This volume expansion will directly increase demand for drug delivery devices, particularly disposable injection systems

Significant fat loss usually begins once you reach a stabilised, higher therapeutic maintenance dose